- 中文名稱
PROZ 一抗
- 英文名字
- PROZ Primary antibody
- 供應(yīng)商
- Promab
- 產(chǎn)品貨號(hào)
- PMB-20362
- 產(chǎn)品報(bào)價(jià)
- ¥詢價(jià)/100ul

- 產(chǎn)品說明書
- 點(diǎn)擊查看
- 購(gòu)買方式
- Promab中國(guó)區(qū)現(xiàn)貨中心已經(jīng)建立,95%產(chǎn)品中國(guó)有現(xiàn)貨庫(kù)存。銀行轉(zhuǎn)賬、電匯、支票、現(xiàn)金,在線支付寶及網(wǎng)銀支付,或直接與我們電話聯(lián)系。本公司所有產(chǎn)品僅供科研使用,不用于臨床診斷。
- 產(chǎn)品新聞

- 背景資料
- PROZ protein Z, vitamin K-dependent plasma glycoprotein. It is 62 kDa large and 396 amino acids long. It has four domains: a gla-rich region, two EGF-like domains and a trypsin-like domain. It lacks the serine residue that would make it catalytically active as a serine protease. It is a member of the coagulation cascade, the group of blood proteins that leads to the formation of blood clots. It is vitamin K-dependent, and its functionality is therefore impaired in warfarin therapy. It is a glycoprotein. Although it is not enzymatically active, it is structurally related to several serine proteases of the coagulation cascade: factors VII, IX, X and protein C. The carboxyglutamate residues (which require vitamin K) bind protein Z to phospholipid surfaces. The main role of protein Z appears to be the degradation of factor Xa. This is done by protein Z-related protease inhibitor (ZPI), but the reaction is accelerated 1000-fold by the presence of protein Z. Oddly, ZPI also degrades factor XI, but this reaction does not require the presence of protein Z. In some studies, deficiency states have been associated with a propensity to thrombosis. Others, however, link it to bleeding tendency; there is no clear explanation for this, as it acts physiologically as an inhibitor, and deficiency would logically have led to a predisposition for thrombosis.
- 應(yīng)用類型
- WB
- 免疫原
- Purified recombinant fragment of PROZ expressed in E. Coli.
- 來源宿主
- Mouse
- 反應(yīng)性
- Human
- 保存建議
- 4℃短期保存;-20℃長(zhǎng)期保存。避免凍融循環(huán)。
- 其他
- ProMab 生物技術(shù)公司通過整合生物信息學(xué)、分子生物學(xué)、蛋白質(zhì)表達(dá)、純化技術(shù)、基因克隆、微生物學(xué)和免疫學(xué),利用新型高通量技術(shù)開發(fā)重組蛋白、抗體和工程細(xì)胞系并將其商業(yè)化。專注于免疫治療領(lǐng)域,特別是 CAR-T/NK 細(xì)胞技術(shù)。ProMab 還開發(fā)了一種新型的 mRNA 脂質(zhì)納米顆粒(mRNA-LNP)平臺(tái),用于即用型試劑和定制研究服務(wù),以推進(jìn)現(xiàn)有產(chǎn)品并擴(kuò)展到更多的研究領(lǐng)域。

- 注意
-
該頁面的中文產(chǎn)品信息的翻譯,僅供參考。準(zhǔn)確的產(chǎn)品信息請(qǐng)以廠家的英文說明書為準(zhǔn)。下單前,請(qǐng)瀏覽說明書確認(rèn)。
-